Tagged Content
  • Sensor-Tech Presents its Bionic Vision Solution to Restore Eyesight

    Elvis , a bionic eye solution created by Skolkovo company Sensor-Tech, is the first step towards restoring eyesight using artificial intelligence. The device sends images of object outlines in real-time directly into the brain using a combination of smart vision...

    01 July, 13:29 Le Jeune
  • Microsoft Adopts Skolkovo Resident’s VR Solution

    Skolkovo resident VR Concept has developed a VR prototyping solution that was recently picked up by the American corporation Microsoft for its “Gorod Innovatsii” program (Urban Innovation). The project is aimed at industry with the goal of increasing...

    22 December, 13:51 Le Jeune
  • Group-IB Cements Foothold in Europe: European HQ in Amsterdam Opens Its Doors

    Image: Group-IB. Amsterdam, 12.11.2020 — Group-IB , a global threat hunting and intelligence company and Skolkovo resident, has opened the doors of its European headquarters in Amsterdam, which will serve as a central hub for the company’s...

    13 November, 13:07 Le Jeune
  • Trepang: Protecting Marine Ecology in the Far East

    Authorities in Primorsky Krai, a province in the far east of Russia on the Pacific coast, are discussing the construction of a chemical fertilizer plant in the Nakhodka region. The famous hydrobiologist Sergei Maslennikov, who is also head of a leading Skolkovo...

    13 November, 12:03 Le Jeune
  • ROBBO Sets Its Gaze on Africa

    ROBBO, a Skolkovo resident company that specializes in helping teach school-age kids robotics, has opened clubs in Nigeria and South Africa, the African continent’s two wealthiest nations. ROBBO has already had significant success in Japan and Finland...

    05 November, 16:28 Le Jeune
  • Rapid Bio's Covid-19 Express Test Ready for Export

    The express test created by Skolkovo resident company Rapid Bio can detect Covid-19 within 10-minutes and with 96% accuracy. The test works by detecting IgM and IgG antibodies. IgM antibodies tell of recent infection and disease onset, while IgG antibodies...

    03 November, 17:04 Le Jeune